Form D · Pharmaceuticals

OrthogenRx, Inc.

Doylestown, PA · CIK 0001584198

Offering snapshot reported Mar 30, 2017 · SEC filing

Reported sold
$300K
Offering amount: $3M
Investors reported
3
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Mar 20, 2017
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Mar 30, 2017Initial$300,000No comparison3SEC filing
Dec 8, 2015Initial$135,313No comparison11SEC filing
Jul 28, 2014AmendmentYet to sellNo comparison0SEC filing
Sep 19, 2013Initial$141,000No comparison8SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-283652

Source: Form D, filed Mar 30, 2017. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Michael Daley Director, Executive, Promoter
David Oster Director
David Owens Director
Tom Petro Director
John Reiss Director
Renee Selman Director
David Toledo Velasquez Director, Executive
Berl Volker Director
Joel Weiner Director, Executive

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
3805 Old Easton Road
Doylestown, PA, 18902